Prostate cancer mortality in the Finnish randomized screening trial

TP Kilpeläinen, TL Tammela, N Malila… - Journal of the …, 2013 - academic.oup.com
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

Prostate Cancer Mortality in the Finnish Randomized Screening Trial.

TP Kilpeläinen, TL Tammela, N Malila… - JNCI: Journal of the …, 2013 - search.ebscohost.com
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

[引用][C] Prostate Cancer Mortality in the Finnish Randomized Screening Trial

TP KILPELÄINEN, TL TAMMELA… - Journal of the …, 2013 - pascal-francis.inist.fr
Prostate Cancer Mortality in the Finnish Randomized Screening Trial CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

[PDF][PDF] Prostate Cancer Mortality in the Finnish Randomized Screening Trial

TP Kilpeläinen, TL Tammela, N Malila, M Hakama… - mortality, 2013 - academia.edu
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

Prostate cancer mortality in the Finnish randomized screening trial.

TP Kilpeläinen, TL Tammela, N Malila… - Journal of the …, 2013 - europepmc.org
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

[引用][C] Prostate Cancer Mortality in the Finnish Randomized Screening Trial

TP Kilpelainen, TL Tammela… - Journal of the …, 2013 - researchportal.helsinki.fi
Prostate Cancer Mortality in the Finnish Randomized Screening Trial — University of
Helsinki Skip to main navigation Skip to search Skip to main content University of Helsinki …

Prostate cancer mortality in the Finnish randomized screening trial.

TP Kilpeläinen, TL Tammela, N Malila, M Hakama… - 2013 - cabidigitallibrary.org
Background: Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

[PDF][PDF] Prostate cancer Mortality in the Finnish randomized Screening trial

TP Kilpeläinen, TL Tammela, N Malila… - J Natl Cancer …, 2013 - scholar.archive.org
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

Prostate cancer mortality in the finnish randomized screening trial

TP Kilpeläinen, TL Tammela, N Malila… - JOURNAL OF THE …, 2013 - researchportal.tuni.fi
BackgroundProstate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …

Prostate cancer mortality in the Finnish randomized screening trial

TP Kilpeläinen, TL Tammela, N Malila, M Hakama… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …